Skip to content
Buy This GLP
← Research
Safety

Can You Drink Alcohol While Taking Tirzepatide? What the Label Says

Zepbound’s label lists no beverage-alcohol interaction. It warns about dehydration, low blood sugar with certain diabetes medicines, and pancreatitis.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team5 min read
Stomach effects: highest rate across doses vs placeboNausea8%29%Diarrhea8%23%Vomiting2%13%Upper: placebo. Lower: highest rate in a tirzepatide dose group.

The Zepbound prescribing information does not list beverage alcohol as a drug interaction. Its listed interactions include insulin or insulin secretagogues, such as sulfonylureas, and oral medicines whose absorption can be affected by delayed stomach emptying. The label gives no safe drinking amount. If you take other medicines or have a history of pancreatitis, ask your prescriber how that affects your risk.[1]

Stomach symptoms and dehydration

In the Zepbound weight-management trials, nausea occurred in 25% to 29% of participants across tirzepatide doses, compared with 8% on placebo. Vomiting occurred in 8% to 13%, compared with 2% on placebo. These rates come from the drug trials. The label does not quantify how alcohol changes them.[1]

The label says most reported kidney injuries occurred after nausea, vomiting, or diarrhea led to dehydration. It recommends monitoring kidney function when adverse reactions could cause fluid loss, especially when starting treatment or increasing the dose.[1]

Low blood sugar and other diabetes medicines

If you take insulin or a sulfonylurea, the guide to low blood sugar with GLP-1 treatment explains why the rest of your medication list matters. In a Zepbound trial in people with type 2 diabetes, glucose below 54 mg/dL was reported in 4.2% of participants receiving Zepbound and 1.3% receiving placebo. Among participants receiving Zepbound, the rate was 10.3% with a sulfonylurea and 2.1% without one. Ask your diabetes care team before drinking or changing medication doses.[1]

When abdominal pain needs attention

If you have a history of pancreatitis, tell your prescriber before starting tirzepatide. The Zepbound label warns that persistent or severe abdominal pain, sometimes spreading to the back, can be a sign of pancreatitis, with or without nausea or vomiting. If pancreatitis is suspected, stop taking Zepbound and seek medical care promptly.[1]

What the alcohol pilot measured

Researchers recruited 24 adults with obesity and analyzed 20 after an alcohol challenge. Ten already took a GLP-1 medication, and ten took no weight-loss medication. Breath alcohol and perceived alcohol effects rose later in the medication group. Only two participants took tirzepatide, and medication use was not randomized. The study could not isolate a tirzepatide-specific effect or establish a safe drinking amount.[2]

The semaglutide trial for alcohol use disorder examined whether treatment reduced drinking. Its outcomes address a different question from the immediate effects of drinking while on tirzepatide.

Frequently asked

Can you drink alcohol while taking tirzepatide?
The Zepbound label lists no beverage-alcohol interaction and provides no safe drinking limit. Ask your prescriber if you have diabetes, take medicines that can lower blood sugar, or have had pancreatitis.
Does tirzepatide change how quickly you feel alcohol?
A pilot found delayed effects among people taking several GLP-1 medications. Only two participants took tirzepatide, so the study could not establish its specific effects.

Sources

  1. [1] Eli Lilly and Company (2026). Zepbound (tirzepatide) prescribing information DailyMed, U.S. National Library of Medicine. Source
  2. [2] Quddos F, et al. (2025). A preliminary study of the physiological and perceptual effects of GLP-1 receptor agonists during alcohol consumption in people with obesity Scientific Reports. PMID 41093891

More in Safety